Katherine A. Janeway, MD MMSc

Senior Physician
Department of Pediatrics, Dana-Farber / Boston Children’s Cancer and Blood Disorders Center Harvard Medical School
Boston, Massachusetts, United States

Disclosure information not submitted.

Presentation(s):

• Paper 05 - SYSTEMATIC CHARACTERIZATION AND TARGETING OF MASTER REGULATOR DEPENDENCIES IN COEXISTING OSTEOSARCOMA SUBPOPULATIONS

  Thursday, November 14, 2024
  8:30 AM – 10:00 AM PST

• Paper 70 - PHASE 2 STUDY TO EVALUATE PALBOCICLIB (IBRANCE®) IN COMBINATION WITH IRINOTECAN AND TEMOZOLOMIDE IN PEDIATRIC PATIENTS WITH RECURRENT OR REFRACTORY EWING SARCOMA

  Saturday, November 16, 2024
  8:00 AM – 9:00 AM PST

• Paper 71 - SECOND MALIGNANT NEOPLASM FOLLOWING TREATMENT FOR NON-METASTATIC EWING SARCOMA IN PATIENTS ENROLLED ON FRONTLINE PHASE 3 CLINICAL TRIALS: A REPORT FROM CHILDREN'S ONCOLOGY GROUP

  Saturday, November 16, 2024
  8:00 AM – 9:00 AM PST